Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-001627
Filing Date
2013-01-10
Accepted
2013-01-10 09:00:48
Documents
1
Period of Report
2013-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v331819_6k.htm 6-K 10149
  Complete submission text file 0001144204-13-001627.txt   11063
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 13521607
SIC: 2834 Pharmaceutical Preparations